Diagnosis of latent tuberculosis infection among immunodeficient individuals: Review of concordance between interferon-γ release assays and the tuberculin skin test

British Journal of Biomedical Science

Volumn 71, Issue 3, 2014, Pages 115-124

  Mamishi, S ^a,b   Pourakbari, B ^a   Marjani, M ^c   Mahmoudi, S ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Immunosuppression; Interferon gamma release tests; Latent tuberculosis

Indexed keywords

DIAGNOSTIC TEST; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOCOMPROMIZED PATIENT; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS TEST KIT; PRIORITY JOURNAL; REVIEW; TUBERCULIN TEST; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; REPRODUCIBILITY;

HUMANS; IMMUNOCOMPROMISED HOST; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; REPRODUCIBILITY OF RESULTS; TUBERCULIN TEST;

EID: 84907951172     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2014.11669976     Document Type: Review

References (80)

1. World Health Organization. Global tuberculosis report 2012. Geneva: WHO, 2012.
2. Cobanoglu N, Ozcelik U, Kalyoncu U et al. Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers. Int J Tuberc Lung Dis 2007; 11 (11): 1177-82.
3. Smirnoff M, Patt C, Seckler B, Adler JJ. Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest 1998; 113 (1): 25-7.
4. Lee S, Chou K, Su I et al. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection 2009; 37 (2): 96-102.
5. Chung W, Zheng Z, Sung J et al. Validity of interferon-g-release assays for the diagnosis of latent tuberculosis in haemodialysis patients. Clin Microbiol Infect 2010; 16 (7): 960-5.
6. Passalent L, Khan K, Richardson R, Wang J, Dedier H, Gardam M. Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT. TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol 2007; 2 (1): 68-73.
7. Triverio PA, Bridevaux PO, Roux-Lombard P et al. Interferongamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol Dial Transplant 2009; 24 (6): 1952-6.
8. Lindemann M, Dioury Y, Beckebaum S et al. Diagnosis of tuberculosis infection in patients awaiting liver transplantation. Hum Immunol 2009; 70 (1): 24-8.
9. Verma A, Dhawan A, Wade JJ et al. Mycobacterium tuberculosis infection in pediatric liver transplant recipients. Pediatr Infect Dis J 2000; 19 (7): 625-30.
10. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149 (3): 177-84.
11. Mazurek GH, Jereb JA, Vernon A, LoBue P, Goldberg S, Castro KG; IGRA Expert Committee; Centers for Disease Control and prevention (CDC). MMWR Recomm Rep 2010; 59 (RR-5): 1-25.
12. Al Jahdali HH, Baharoon S, Abba AA et al. Saudi guidelines for testing and treatment of latent tuberculosis infection. Ann Saudi Med 2010; 30 (1): 38-49.
13. Lagrange PH, Herrmann JL. Diagnosing latent tuberculosis infection in the HIV era. Open Respiry Med J 2008; 2: 52-9.
14. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33 (1): 159-74.
15. Ramos J, Robledano C, Masiá M et al. Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB gold in tube, T-SPOT. TB and tuberculin skin test. BMC Infect Dis 2012; 12: 169.
16. Balcells ME, Pérez CM, Chanqueo L et al. A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile. Int J Infect Dis 2008; 12 (6): 645-52.
17. Bocchino M, Matarese A, Bellofiore B et al. Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment. Eur J Clin Microbiol Infect Dis 2008; 27 (10): 907-13.
18. Latorre I, Martinez-Lacasa X, Font R et al. IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection. BMC Infect Dis 2010; 10: 348.
19. Richeldi L, Losi M, D'Amico R et al. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest 2009; 136 (1): 198-204.
20. Cheallaigh CN, Fitzgerald I, Grace J et al. Interferon gamma release assays for the diagnosis of latent TB infection in HIVinfected individuals in a low TB burden country. PLoS One 2013; 8 (1): e53330.
21. Luetkemeyer AF, Charlebois ED, Flores LL et al. Comparison of an interferon-γ release assay with tuberculin skin testing in HIVinfected individuals. Am J Respir Crit Care Med 2007; 175 (7): 737-42.
22. Rangaka MX, Wilkinson KA, Seldon R et al. Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2007; 175 (5): 514-20.
23. Jones S, De Gijsel D, Wallach F, Gurtman A, Shi Q, Sacks H. Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int J Tuberc Lung Dis 2007; 11 (11): 1190-5.
24. Sauzullo I, Mengoni F, Scrivo R et al. Evaluation of QuantiFERONTB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment. Int J Tuberc Lung Dis 2010; 14 (7): 834-40.
25. Mandalakas AM, van Wyk S, Kirchner HL et al. Detecting tuberculosis infection in HIV-infected children: a study of diagnostic accuracy, confounding and interaction. Pediatr Infect Dis J 2013; 32 (3): e111-8.
26. Stephan C, Wolf T, Goetsch U et al. Comparing QuantiFERONtuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS 2008; 22 (18): 2471-9.
27. Elzi L, Steffen I, Furrer H et al. Improved sensitivity of an interferon-gamma release assay (T-SPOT. TB) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-Infection. BMC Infect Dis 2011; 11: 319.
28. Talati NJ, Seybold U, Humphrey B et al. Poor concordance between interferon-γ release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect Dis 2009; 9: 15.
29. Mandalakas A, Hesseling A, Chegou N et al. High level of discordant IGRA results in HIV-infected adults and children. Int J Tuberc Lung Dis 2008; 12 (4): 417-23.
30. Kobashi Y, Mouri K, Obase Y, Fukuda M, Miyashita N, Oka M. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. Eur Respir J 2007; 30 (5): 945-50.
31. Karam F, Mbow F, Fletcher H et al. Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS One 2008; 3 (1): e1441.
32. Zhang M, Wang H, Liao M et al. Diagnosis of latent tuberculosis infection in bacille Calmette-Guerin vaccinated subjects in China by interferon-gamma ELISpot assay. Int J Tuberc Lung Dis 2010; 14 (12): 1556-63.
33. Talati N, Gonzalez-Diaz E, Mutemba C et al. Diagnosis of latent tuberculosis infection among HIV discordant partners using interferon gamma release assays. BMC Infect Dis 2011; 11: 264.
34. Wolf T, Goetsch U, Oremek G et al. Tuberculosis skin test, but not interferon-gamma-releasing assays is affected by BCG vaccination in HIV patients. J Infect 2013; 66 (4): 376-80.
35. Hadaya K, Bridevaux PO, Roux-Lombard P et al. Contribution of interferon-gamma release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation. Transplantation 2013; 95 (12): 1485-90.
36. Kim SH, Lee SO, Park IA et al. Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation. Transpl Infect Dis 2010; 12 (2): 113-9.
37. Chung WK, Zheng ZL, Kim HS et al. Serial testing of interferongamma-release assays for the diagnosis of latent tuberculosis in hemodialysis patients. J Infect 2010; 61 (2): 144-9.
38. Seyhan EC, Sokucu S, Altin S et al. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients. Transpl Infect Dis 2010; 12 (2): 98-105.
39. Winthrop KL, Nyendak M, Calvet H et al. Interferon-gamma release assays for diagnosing Mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol 2008; 3 (5): 1357-63.
40. Maden E, Bekci TT, Kesli R et al. Evaluation of performance of quantiferon assay and tuberculin skin test in end stage renal disease patients receiving hemodialysis. New Microbiol 2011; 34 (4): 351-6.
41. Sayarlioglu H, Gul M, Eren Dagli C et al. QuantiFERON-TB Gold test for screening latent tuberculosis infection in hemodialysis patients. Tuberk Toraks 2011; 59 (2): 105-10.
42. Stefan D, Dippenaar A, Detjen A et al. Interferon-gamma release assays for the detection of Mycobacterium tuberculosis infection in children with cancer. Int J Tuberc Lung Dis 2010; 14 (6): 689-94.
43. Silverman M, Reynolds D, Kavsak P, Garay J, Daly A, Davis I. Use of an interferon-gamma based assay to assess bladder cancer patients treated with intravesical BCG and exposed to tuberculosis. Clin Biochem 2007; 40 (12): 913-5.
44. de Leon DP, Acevedo-Vasquez E, Alvizuri S et al. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J Rheumatol 2008; 35 (5): 776-81.
45. Manuel O, Humar A, Preiksaitis J et al. Comparison of Quantiferon-TB Gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007; 7 (12): 2797-801.
46. Matulis G, Jüni P, Villiger PM, Gadola SD. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigenspecific interferon-γ assay. Ann Rheum Dis 2008; 67 (1): 84-90.
47. Baboolal S, Ramoutar D, Akpaka PE. Comparison of the QuantiFERON-TB Gold assay and tuberculin skin test to detect latent tuberculosis infection among target groups in Trinidad & Tobago. Rev Panam Salud Pública 2010; 28 (1): 36-42.
48. Dheda K, Lalvani A, Miller RF et al. Performance of a T-cellbased diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS 2005; 19 (17): 2038-41.
49. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-γ test. Respir Res 2006; 7: 56.
50. Jiang W, Shao L, Zhang Y et al. High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-γ release assay among HIV-infected individuals in BCG-vaccinated area. BMC Immunol 2009; 10: 31.
51. Diel R, Loddenkemper R, Meywald-Walter K, Gottschalk R, Nienhaus A. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot. TB test in contact investigations for tuberculosis. Chest 2009; 135 (4): 1010-8.
52. Arend SM, Thijsen SF, Leyten EM et al. Comparison of two interferon-γ assays and tuberculin skin test for tracing tuberculosis contacts. Am J Resp Crit Care Med 2007; 175 (6): 618-27.
53. Bloch AB. Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the advisory council for the elimination of tuberculosis. MMWR Recomm Rep 1995; 44 (RR-11): 19-34.
54. McColloster P, Neff NE. Outpatient management of tuberculosis. Am Fam Physician 1996; 53 (5): 1579-94.
55. Hauck FR, Neese BH, Panchal AS, El-Amin W. Identification and management of latent tuberculosis infection. Am Fam Physician 2009; 79 (10): 879-86.
56. Ferrara G, Losi M, Meacci M et al. Routine hospital use of a new commercial whole blood interferon-γ assay for the diagnosis of tuberculosis infection. Am J Resp Crit Care Med 2005; 172 (5): 631-5.
57. Ferrara G, Losi M, D'Amico R et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006; 367 (9519): 1328-34.
58. Bruzzese E, Bocchino M, Assante L et al. Gamma interferon release assays for diagnosis of tuberculosis infection in immunecompromised children in a country in which the prevalence of tuberculosis is low. J Clin Microbiol 2009; 47 (7): 2355-7.
59. Lee E, Holzman RS. Evolution and current use of the tuberculin test. Clin Infect Dis 2002; 34 (3): 365-70.
60. Holty JEC, Gould MK, Meinke L, Keeffe EB, Ruoss SJ. Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data. Liver Transpl 2009; 15 (8): 894-906.
61. Jafri SM, Singal AG, Kaul D, Fontana RJ. Detection and management of latent tuberculosis in liver transplant patients. Liver Transpl 2011; 17 (3): 306-14.
62. Simon TA, Paul S, Wartenberg D, Tokars JI. Tuberculosis in hemodialysis patients in New Jersey: a statewide study. Infect Control Hosp Epidemiol 1999; 20 (9): 607-9.
63. Moore DA, Lightstone L, Javid B, Friedland JS. High rates of tuberculosis in end-stage renal failure: the impact of international migration. Emerg Infect Dis 2002; 8 (1): 77-8.
64. Andrew OT, Schoenfeld PY, Hopewell PC, Humphreys MH. Tuberculosis in patients with end-stage renal disease. Am J Med 1980; 68 (1): 59-65.
65. Malhotra K, Parashar M, Sharma R et al. Tuberculosis in maintenance haemodialysis patients. Study from an endemic area. Postgrad Med J 1981; 57 (670): 492-8.
66. Shankar MS, Aravindan A, Sohal PM et al. The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant 2005; 20 (12): 2720-4.
67. Poduval R, Hammes M. Tuberculosis screening in dialysis patients: is the tuberculin test effective? Clin Nephrol 2003; 59 (6): 436-40.
68. Fang HC, Chou KJ, Chen CL et al. Tuberculin skin test and anergy in dialysis patients of a tuberculosis-endemic area. Nephron 2002; 91 (4): 682-7.
69. Woeltje KF, Mathew A, Rothstein M, Seiler S, Fraser VJ. Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis 1998; 31 (5): 848-52.
70. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146 (5): 340-54.
71. Hoogewerf M, Boland GJ, Hoepelman AI, Boer WH, Mudrikova T. No influence of haemodialysis on interferon production in the QuantiFERON-TB Gold-In-Tube test. J Nephrol 2011; 24 (5): 625-30.
72. Lee SS, Chou KJ, Dou HY et al. High prevalence of latent tuberculosis infection in dialysis patients using the interferongamma release assay and tuberculin skin test. Clin J Am Soc Nephrol 2010; 5 (8):1451-7.
73. Sester M, Sester U, Clauer P et al. Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int 2004; 65 (5): 1826-34.
74. Richardson RM. The diagnosis of tuberculosis in dialysis patients. Semin Dial 2012; 25 (4): 419-22.
75. Lewinsohn DA, Lobato MN, Jereb JA. Interferon-gamma release assays: new diagnostic tests for Mycobacterium tuberculosis infection, and their use in children. Curr Opin Pediatr 2010; 22 (1): 71-6.
76. Haustein T, Ridout DA, Hartley JC et al. The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J 2009; 28 (8): 669-73.
77. Inoue T, Nakamura T, Katsuma A et al. The value of QuantiFERON TB-Gold in the diagnosis of tuberculosis among dialysis patients. Nephrol Dial Transplant 2009; 24 (7): 2252-7.
78. Gideon HP, Flynn JL. Latent tuberculosis: what the host "sees"? Immunol Res 2011; 50 (2-3): 202-12.
79. Kang YA, Lee HW, Yoon HI et al. Discrepancy between the tuberculin skin test and the whole-blood interferon-γ assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005; 293 (22): 2756-61.
80. Denkinger C, Dheda K, Pai M. Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect 2011; 17 (6): 806-14.